Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Hirsch

Showing results (171-180 of 265) with videos related to

Pageof 27
Sort By:
Psychosomatics|January 1, 1990
A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgiaO S Surman, T Flynn, R T Schooley, et al.
Cellular Immunology|January 1, 1975
Cellular immunity in the mouse. IV. Altered thymic-dependent lymphocyte reactivity in the chronic graft vs host reaction and leukemia virus activationS M Phillips, H Gleichmann, M S Hirsch, et al.
Annals of Internal Medicine|November 1, 1978
Cytomegalovirus infection in dialysis patients and personnelN A Tolkoff-Rubin, R H Rubin, E E Keller, et al.
Archives of Virology|January 1, 1992
Eosinophils as host cells for HIV-1B Conway, P Baskar, L J Bechtel, et al.
Science (New York, N.Y.)|April 1, 1988
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individualsB D Walker, C Flexner, T J Paradis, et al.
Transplantation|February 1, 1981
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipientsR H Rubin, A B Cosimi, M S Hirsch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptaseD Zhang, A M Caliendo, J J Eron, et al.
Annals of Internal Medicine|September 1, 1985
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanineD Felsenstein, D J D'Amico, M S Hirsch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonK L Hartshorn, M W Vogt, T C Chou, et al.
Lancet (London, England)|March 8, 1986
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDSM W Vogt, D J Witt, D E Craven, et al.
Pageof 27

Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
Psychosomatics|January 1, 1990
A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgiaO S Surman, T Flynn, R T Schooley, et al.
Cellular Immunology|January 1, 1975
Cellular immunity in the mouse. IV. Altered thymic-dependent lymphocyte reactivity in the chronic graft vs host reaction and leukemia virus activationS M Phillips, H Gleichmann, M S Hirsch, et al.
Annals of Internal Medicine|November 1, 1978
Cytomegalovirus infection in dialysis patients and personnelN A Tolkoff-Rubin, R H Rubin, E E Keller, et al.
Archives of Virology|January 1, 1992
Eosinophils as host cells for HIV-1B Conway, P Baskar, L J Bechtel, et al.
Science (New York, N.Y.)|April 1, 1988
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individualsB D Walker, C Flexner, T J Paradis, et al.
Transplantation|February 1, 1981
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipientsR H Rubin, A B Cosimi, M S Hirsch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Resistance to 2',3'-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptaseD Zhang, A M Caliendo, J J Eron, et al.
Annals of Internal Medicine|September 1, 1985
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanineD Felsenstein, D J D'Amico, M S Hirsch, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonK L Hartshorn, M W Vogt, T C Chou, et al.
Lancet (London, England)|March 8, 1986
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDSM W Vogt, D J Witt, D E Craven, et al.
Pageof 27